Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial

OBJECTIVES: General: To assess the safety, efficacy and dose response of convalescent plasma (CP) transfusion in severe COVID-19 patients Specific: a. To identify the appropriate effective dose of CP therapy in severe patients b. To identify the efficacy of the therapy with their end point based on...

Descripción completa

Detalles Bibliográficos
Autores principales: Chowdhury, Fazle Rabbi, Hoque, Ashraful, Chowdhury, Forhad Uddin Hasan, Amin, Md. Ruhul, Rahim, Abdur, Rahman, M. Mujibur, Yasmin, Rubina, Amin, Md. Robed, Miah, Md. Titu, Kalam, Md. Abul, Rahman, Md. Sayedur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586693/
https://www.ncbi.nlm.nih.gov/pubmed/33106167
http://dx.doi.org/10.1186/s13063-020-04734-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586693/
https://www.ncbi.nlm.nih.gov/pubmed/33106167
http://dx.doi.org/10.1186/s13063-020-04734-z

Ejemplares similares